athenahealth (ATHN) May calls active after Elliott Associates discloses stake

Go back to athenahealth (ATHN) May calls active after Elliott Associates discloses stake

athenahealth (ATHN) PT Raised to $154 at Oppenheimer Following Investor Meetings

May 19, 2017 10:18 AM EDT

Oppenheimer raised its price target on athenahealth (NASDAQ: ATHN) to $154.00 (from $119.00) while maintaining an Outperform rating after hosting investor meetings with management.

Management expressed confidence in the new guidance, which incorporates 1Q trends, but physician utilization remains a wild card. On the... More

athenahealth (ATHN) PT Raised to $140 at Cantor Fitzgerald; Reiterates Overweight

May 19, 2017 7:41 AM EDT

Cantor Fitzgerald raised its price target on athenahealth (NASDAQ: ATHN) to $140.00 (from $118.00) while maintaining a Overweight rating. Elliot Associates announced a 9.2% economic interest in athenaHealth. Analyst Steven Halper expects Elliot to focus management on improving operations rather than an outright sale of the... More

Athenahealth (ATHN) 'Looks Forward' to Discussions with Elliot Management as Shares Surge

May 18, 2017 1:20 PM EDT

Athenahealth (NASDAQ: ATHN) said it was aware of Elliot's Management new stake in the company and looks forward to discussing the firm views and the company's actions being taken to enhance shareholder value.

"We are aware of Elliots filing and... More

athenahealth (ATHN) PT Raised to $147 at Evercore ISI Following Elliott 13D

May 18, 2017 10:45 AM EDT

Evercore ISI raised its price target on athenahealth (NASDAQ: ATHN) to $147.00 (from $118.00) while maintaining a Outperform rating following the Elliott Associates 13D.

Analyst Ross Muken said while the filing surprised many, it is not altogether shocking that a relatively underperforming, though strategically well-placed... More